Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVARI study
DRKS00024585Phase 3Terminated
- Sponsor
- Pohl-Boskamp
- Start
- Feb 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing PB432 with Placebo (2 arms). Started Feb 2021; status: terminated.
02
Drugs
ELOM-080
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on DRKS00024585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00024585.